• Positive net cash flow from operating activities of $1.362 million
• Investing activities resulted in net cash outflow of $1.741 million
• Financing activities resulted in net cash outflow of $255,000

SomnoMed Ltd, a leading provider of sleep treatment solutions, has reported its quarterly cashflow for Q4 2025. The company generated positive net cash flow from operating activities of $1.362 million, driven by strong customer receipts of $29.343 million. However, the company also had significant outflows, including $10.590 million for product manufacturing and operating costs, $10.891 million for staff costs, and $4.430 million for administration and corporate costs. Investing activities resulted in a net cash outflow of $1.741 million, primarily due to payments for property, plant and equipment ($1.249 million) and intellectual property ($492,000). Financing activities resulted in a net cash outflow of $255,000, mainly from the repayment of borrowings. Overall, the company maintained a strong cash position, with $17.293 million in cash and cash equivalents at the end of the quarter.